UBS Group’s Titan Pharmaceuticals TTNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4K Buy
3,427
+833
+32% +$3.5K ﹤0.01% 7338
2025
Q1
$9.16K Sell
2,594
-73
-3% -$258 ﹤0.01% 7395
2024
Q4
$8.69K Sell
2,667
-2,106
-44% -$6.87K ﹤0.01% 7152
2024
Q3
$25.2K Buy
4,773
+4,772
+477,200% +$25.1K ﹤0.01% 6034
2024
Q2
$6 Hold
1
﹤0.01% 8225
2024
Q1
$7 Buy
+1
New +$7 ﹤0.01% 7955
2023
Q4
Hold
0
-$2 7995
2023
Q3
Hold
0
8204
2023
Q2
Sell
-76
Closed -$1.27K 8428
2023
Q1
$1.27K Buy
76
+68
+850% +$1.13K ﹤0.01% 7671
2022
Q4
$129 Sell
8
-551
-99% -$8.89K ﹤0.01% 9167
2022
Q3
$12K Sell
559
-788
-59% -$16.9K ﹤0.01% 7085
2022
Q2
$15K Buy
1,347
+991
+278% +$11K ﹤0.01% 6281
2022
Q1
$7K Buy
356
+166
+87% +$3.26K ﹤0.01% 7788
2021
Q4
$4K Sell
190
-165
-46% -$3.47K ﹤0.01% 8426
2021
Q3
$13K Sell
355
-59
-14% -$2.16K ﹤0.01% 6546
2021
Q2
$22K Sell
414
-759
-65% -$40.3K ﹤0.01% 6149
2021
Q1
$70K Buy
1,173
+870
+287% +$51.9K ﹤0.01% 5246
2020
Q4
$20K Buy
303
+297
+4,950% +$19.6K ﹤0.01% 5937
2020
Q3
$1K Sell
6
-188
-97% -$31.3K ﹤0.01% 6954
2020
Q2
$36K Buy
194
+68
+54% +$12.6K ﹤0.01% 5302
2020
Q1
$18K Buy
126
+55
+77% +$7.86K ﹤0.01% 5651
2019
Q4
$8K Buy
71
+69
+3,450% +$7.78K ﹤0.01% 6325
2019
Q3
$0 Sell
2
-1
-33% ﹤0.01% 7161
2019
Q2
$2K Sell
3
-10
-77% -$6.67K ﹤0.01% 6757
2019
Q1
$14K Buy
13
+8
+160% +$8.62K ﹤0.01% 5764
2018
Q4
$4K Buy
5
+4
+400% +$3.2K ﹤0.01% 6710
2018
Q3
$1K Buy
+1
New +$1K ﹤0.01% 6923
2018
Q2
Sell
-1
Closed -$2K 7155
2018
Q1
$2K Buy
+1
New +$2K ﹤0.01% 6655
2017
Q4
Sell
-1
Closed -$8K 6983
2017
Q3
$8K Hold
1
﹤0.01% 6089
2017
Q2
$4K Buy
+1
New +$4K ﹤0.01% 6268
2017
Q1
Sell
-1
Closed -$13K 6273
2016
Q4
$13K Hold
1
﹤0.01% 5815
2016
Q3
$11K Buy
+1
New +$11K ﹤0.01% 5817
2016
Q2
Hold
0
-$2K 6429
2016
Q1
Hold
0
-$4K 6447
2015
Q4
Hold
0
6400